echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Practice Guidelines for Patients with Rheumatoid Arthritis

    Practice Guidelines for Patients with Rheumatoid Arthritis

    • Last Update: 2022-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In recent years, the guidelines for the diagnosis and treatment of rheumatoid arthritis (RA) by clinical experts have been continuously updated.


    01RA is a chronic, systemic, autoimmune disease;

    02 A positive rheumatoid factor (RF) alone cannot diagnose RA;

    03RA has a certain genetic predisposition;

    04 Anti-cyclic citrullinated polypeptide (CCP) antibody testing predicts the severity of joint destruction in patients with RA;

    05Acupuncture can assist in the treatment of RA;

    06 RA patients with anxiety symptoms can seek psychological intervention and drug treatment;

    07 RA patients with sleep disorders can try psychological intervention or drug treatment, and appropriate exercise;

    08RA patients should participate in exercise and choose appropriate exercise methods according to their condition;

    09RA patients should quit smoking;

    10 For patients with RA who have discontinued glucocorticoids and have been in remission for more than half a year, dose reduction of biological agents can be considered;

    11 Methotrexate is contraindicated during pregnancy and lactation, and pregnancy can be prepared if it is stopped for more than 3 months;

    12 Leflunomide is contraindicated during pregnancy and lactation, and pregnancy can be prepared when the concentration of the drug is not detected in the blood;

    13 RA patients should be supplemented with calcium, vitamin D and bisphosphonates to prevent and/or treat osteoporosis;

    14 Color ultrasonography for synovitis in stable RA patients predicts disease recurrence;

    15RA patients should pay attention to the prevention, monitoring and treatment of liver injury;

    16RA patients benefit greatly from participating in the fellowship


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.